BOLT - Bolt Biotherapeutics, Inc.
Previous close
0.5136
-0.002 -0.467%
Share volume: 300
Last Updated: Thu 26 Dec 2024 08:23:02 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.52
0.00
-0.47%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-10 | 2023-03-29 | 2023-05-11 | 2023-08-07 | 2023-11-09 | 2024-03-21 | 2024-05-14 | |
| Total revenue | 1.393 M | 2.112 M | 1.411 M | 1.826 M | 1.433 M | 2.528 M | 2.089 M | 5.274 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.393 M | 2.112 M | 1.411 M | 1.826 M | 1.433 M | 2.528 M | 2.089 M | 5.274 M | |
| 51.62% | -33.19% | 29.41% | -21.52% | 76.41% | -17.37% | 152.47% | |||
| Operating expenses | 24.452 M | 24.458 M | 22.451 M | 20.241 M | 21.265 M | 20.711 M | 21.855 M | 22.366 M | |
| Selling general and admin | 5.532 M | 5.485 M | 5.606 M | 5.616 M | 5.621 M | 5.760 M | 5.533 M | 5.837 M | |
| Research and development | 18.920 M | 18.973 M | 16.845 M | 14.625 M | 15.644 M | 14.951 M | 16.322 M | 16.529 M | |
| Total expenses | 24.452 M | 24.458 M | 22.451 M | 20.241 M | 21.265 M | 20.711 M | 21.855 M | 22.366 M | |
| 0.02% | -8.21% | -9.84% | 5.06% | -2.61% | 5.52% | 2.34% | |||
| Operating income | -23.059 M | -22.346 M | -21.040 M | -18.415 M | -19.832 M | -18.183 M | -19.766 M | -17.092 M | |
| Ebit | -23.059 M | -22.346 M | -21.040 M | -18.415 M | -19.832 M | -18.183 M | -19.766 M | -17.092 M | |
| Pretax income | -22.664 M | -21.759 M | -19.997 M | -16.980 M | -18.057 M | -16.257 M | -17.903 M | -10.811 M | |
| -3.99% | -8.10% | -15.09% | 6.34% | -9.97% | 10.12% | -39.61% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -22.664 M | -21.759 M | -19.997 M | -16.980 M | -18.057 M | -16.257 M | -17.903 M | -10.811 M | |
| 3.99% | 8.10% | 15.09% | -6.34% | 9.97% | -10.12% | 39.61% | |||
| Net income | -22.664 M | -21.759 M | -19.997 M | -16.980 M | -18.057 M | -16.257 M | -17.903 M | -10.811 M | |
| 3.99% | 8.10% | 15.09% | -6.34% | 9.97% | -10.12% | 39.61% |